vel Szic, K. S., Declerck, K., Crans, R. A., Diddens, J., Scherf, D. B., Gerhäuser, C., & Berghe, W. V. (2017). Epigenetic silencing of triple negative breast cancer hallmarks by Withaferin A. Oncotarget.
Dyfyniad Arddull Chicagovel Szic, Katarzyna Szarc, Ken Declerck, René A.J Crans, Jolien Diddens, David B. Scherf, Clarissa Gerhäuser, and Wim Vanden Berghe. "Epigenetic Silencing of Triple Negative Breast Cancer Hallmarks By Withaferin A." Oncotarget 2017.
Dyfyniad MLAvel Szic, Katarzyna Szarc, et al. "Epigenetic Silencing of Triple Negative Breast Cancer Hallmarks By Withaferin A." Oncotarget 2017.
Rhybudd: Mae'n bosib nad yw'r dyfyniadau hyn bob amser yn 100% cywir.